Pim1 belongs to a family of serine/threonine kinases, which is involved in the control of cell growth, differentiation, and apoptosis. Pim1 plays a pivotal role in cytokine signaling and is implicated in the development of a large number of tumors, representing a very attractive target for anticancer therapy. In this work, we applied a virtual screening protocol aimed at identifying small molecules able to inhibit Pim1 activity. The search of novel inhibitors was performed through a structure-based molecular modeling approach, taking advantage of the availability of the three-dimensional crystal structure of inhibitors bound to Pim1. Starting from the knowledge of protein–ligand complexes, the software LigandScout was used to generate pharmacophoric models, in turn used as queries to perform a virtual screening of databases, followed by docking experiments. As a result, a restricted set of candidates for biological testing was identified. Finally, among the six compounds selected as potential inhibitors of Pim1, two candidates endowed with a significant activity against Pim1 emerged. Interestingly, one of these compounds has a chemical scaffold different from inhibitors previously identified.
Scheda prodotto non validato
Scheda prodotto in fase di analisi da parte dello staff di validazione
|Titolo:||Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors|
|Rivista:||BIOORGANIC & MEDICINAL CHEMISTRY LETTERS|
|Citazione:||Olla, S., Manetti, F., Crespan, E., Maga, G., Angelucci, A., Schenone, S., et al. (2009). Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 19, 1512-1516.|
|Appare nelle tipologie:||1.1 Articolo in rivista|